The Effect of Two Different Structured Balls on Pain and Fear Levels During Venous Blood Collection in Children

March 5, 2025 updated by: Zeynep Yurdakul

Nurse, PhD Student, Responsible Researcher

Pain causes many physiological and psychological changes in the body, increases the level of anxiety in children, and prolongs examination and other procedures. Pain should be evaluated individually for each child, taking into account individual differences in pain level and response to pain. From the moment of birth, human beings have been exposed to many invasive interventions throughout their lives and experience pain and anxiety as a result. Experiences with childhood pain shape children's future pain responses.

This study, which was planned to stimulate the touch receptors of two different balls used during venous blood collection, is a randomized controlled study in order to determine the effect on the pain and fear levels of children aged 6-12 years. A total of 310 children were included in the study. The experimental groups included in the study were asked to hold the balls with their hands according to their groups, no attempt was made to the control group. The research data were obtained with the Wong-Baker Faces Pain Rating Scale and Child Fear Scale, which will be used in the evaluation. In addition, oxygen saturation and heart rate were evaluated immediately before and after removal of the tourniquet.

Study Overview

Detailed Description

Attempt During the trial, all blood collection procedures will be performed by the same nurse working in the hospital's blood collection unit. The nurse who will perform the procedure works as a pediatric nurse for 15 years.

Control Group;

  • Data on the child and his parents will be collected by the researcher using face-to-face interview technique and recorded in the "Information Form".
  • The child and parent will be informed by showing the Wong-Baker Faces Pain Rating Scale, the Child Fear Scale, and the pulse oximeter.
  • Disinfectant will be poured on the child's and parent's hands.
  • Before the blood draw, the child will be given the Wong-Baker Faces Pain Rating Scale, the Child Fear Scale, and a pen, and will be asked to mark the facial expression appropriate to his current situation.
  • The child who filled out the form will be taken to the blood collection room with his parents, and the child will be seated on the blood collection chair. The child and parent will be informed about the blood collection procedure according to the hospital procedure.
  • Due to the pandemic, in accordance with the hospital procedure, the tourniquet will be disinfected and used after each blood collection.
  • The nurse will determine the child's extremity suitable for vascular access.
  • Standard hospital procedures will be applied throughout the blood collection procedure.
  • Immediately after the procedure, the child will be asked to mark the appropriate facial expression on the Wong-Baker Faces Pain Rating Scale and the Child Fear Scale during the procedure.
  • Disinfectant will be poured on the child's and parent's hands.
  • The child whose blood collection process is completed, and his parents will be thanked for their acceptance to participate in the research and will be ensured to leave the room.

Experimental Groups;

  • Data on the child and his parents will be collected by the researcher using face-to-face interview technique. It will be saved in the "Information Form".
  • The child and parent will be informed by showing the Wong-Baker Faces Pain Rating Scale, the Child Fear Scale, and the pulse oximeter.
  • Disinfectant will be poured on the child's and parent's hands.
  • Before the blood draw, the child will be given the Wong-Baker Faces Pain Rating Scale, the Child Fear Scale, and a pen, and will be asked to mark the facial expression appropriate to his current situation.
  • The child who filled out the form will be taken to the blood collection room with his parents, and the child will be seated on the blood collection chair. The child and parent will be informed about the blood collection procedure according to the hospital procedure.
  • Due to the pandemic, in accordance with the hospital procedure, the tourniquet will be disinfected and used after each blood collection.
  • The nurse will determine the child's extremity suitable for vascular access.
  • According to randomization, the child was able to hold the ball according to the group (Group 1, Group 2, Group 3, Group 4).

    • Group 1: Serrated ball + extremity group from which venous blood will be taken
    • Group 2: Serrated ball + hand group on the opposite side of the extremity from which venous blood will be taken
    • Group 3: Straight ball + extremity group from which venous blood will be taken
    • Group 4: Flat ball + hand group on the opposite side of the extremity from which venous blood will be taken
    • Control group: Group to be applied standard hospital blood collection procedure
  • Standard hospital procedures will be applied throughout the blood collection procedure.
  • Immediately after the procedure, the child will be asked to mark the appropriate facial expression on the Wong-Baker Faces Pain Rating Scale and the Child Fear Scale during the procedure.
  • Disinfectant will be poured on the child's and parent's hands.
  • The child whose blood collection process is completed, and his parents will be thanked for their acceptance to participate in the research and will be ensured to leave the room.

Study Type

Interventional

Enrollment (Actual)

310

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06000
        • Ankara University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • - The volunteerism of the child and the parent to participate in the research,
  • The child is between the ages of 5-12,
  • The child and the parent speaks Turkish, Taking blood from the cephalic vein,
  • Turnstile not being tied for more than 30 seconds,
  • Not taking any analgesic (systemic or topical), antipyretic, anti-inflammatory drugs in the last 12 hours,
  • Body temperature between 36.5-37.2 ⁰C,
  • Not having a disease that can cause chronic pain,
  • No acute pain or anxiety during the procedure,
  • Absence of skin integrity problems,
  • No obstacle to grip the balls in hand,
  • Children who do not have regular invasive interventions (no chronic diseases that require blood control such as cancer, diabetes),
  • Blood collection was performed at the first attempt,
  • The child does not have any auditory, mental or neurological disability that will affect his participation in the research.

Exclusion Criteria:

  • - The child and the parents are not willing to participate in the research,
  • The child is not between the ages of 5-12,
  • The child and the parent do not speak Turkish, Inability to take blood from the cephalic vein,
  • Turnstile remaining tied for more than 30 seconds,
  • Taking any medication with analgesic (systemic or topical), antipyretic or anti-inflammatory effects in the last 12 hours,
  • Body temperature lower than 36.5 C-37.2 ⁰C,
  • Having a disease that can cause chronic pain,
  • Children who undergo regular invasive interventions (having chronic diseases that require blood control such as cancer, diabetes), Failure to take blood at the first attempt,
  • Any acute pain or anxiety during the procedure,
  • Problems with skin integrity,
  • It has an obstacle to grip the balls,
  • Having an auditory, mental or neurological disability that will affect the child's participation in the research,
  • Children in the control group want or involuntarily hold their parent's hand or something else during the procedure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1
The group holding the serrated ball in the hand on the extremity from which venous blood will be taken
Children in the experimental groups will squeeze the serrated ball during the blood draw.
Other Names:
  • serrated ball
Experimental: Group 2
The group holding the serrated ball in the hand on the opposite side of the extremity from which venous blood will be taken.
Children in the experimental groups will squeeze the serrated ball during the blood draw.
Other Names:
  • serrated ball
Experimental: Group 3
The group holding a smooth ball in the hand on the extremity from which venous blood will be taken
Children in the experimental groups will squeeze the smooth ball during the blood draw.
Other Names:
  • smooth ball
Experimental: Group 4
The group holding a smooth ball in the hand opposite the extremity from which venous blood will be taken.
Children in the experimental groups will squeeze the smooth ball during the blood draw.
Other Names:
  • smooth ball
No Intervention: Group 5
The group that will undergo standard hospital blood collection procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain level as assessed with Wong-Baker Faces Pain Rating Scale
Time Frame: during the procedure
This scale to be used to assess pain in our study was developed by Donna Wong and Connie Morain Baker in 1981 and revised in 1983. The scale is widely used to measure pain intensity in children over the age of three. Pain is scored according to numerical values assigned to faces that show an expression spectrum; smiling face represents no pain (0 points), crying face represents severe pain (10 points). The scale is a valid and reliable tool for measuring procedural pain severity. Permission for the scale was obtained from the official website of the Wong-Baker Faces Foundation. The Turkish translation of the scale was sent by Nick Baker, official site official of the Wong-Baker Faces Foundation.
during the procedure
Fear as assessed using the Child Fear Scale
Time Frame: during the procedure
It is used to determine the child's fear and anxiety level. Fear and anxiety are assessed on a five-point scale. The single-item scale consists of five facial expressions regardless of gender. The first facial expression of the scale is neutral and has a value of zero. The last facial expression is worth four points expressing extreme fear. In this study, Child Fear Scale will be used to evaluate the fear levels of children in the experimental and control groups before and after the bloodletting procedure. The scale was introduced into the Turkish language by Gerçeker et al. (2018). Test-retest reliability of the Child Fear Scale was found to be quite high, and its content validity index was determined as 0.89. Since the scale is in the form of scoring, item-total correlation and Cronbach alpha coefficient could not be calculated.
during the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Figen Işık ESENAY, Assistant Professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 4, 2021

Primary Completion (Actual)

June 18, 2021

Study Completion (Actual)

June 30, 2021

Study Registration Dates

First Submitted

October 24, 2020

First Submitted That Met QC Criteria

November 10, 2020

First Posted (Actual)

November 17, 2020

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 5, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Pediatric Nursing

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The child is between the ages of 6-12,

  • Volunteering of the child and parent to participate in the research,
  • Acceptance of wearing the transparent mask provided by the researcher, which clearly shows the facial expression, throughout the procedure,
  • Turkish speaking of the child and the parent,
  • The child does not have an auditory, mental or neurological disability that will affect his participation in the research,
  • Absence of problems related to skin integrity on the hand,
  • There is no obstacle to the grasp of the balls,
  • Not taking analgesic (systemic or topical), antipyretic, anti-inflammatory drugs in the last 12 hours,
  • Body temperature between 36.5-37.2 ⁰C,
  • Absence of acute pain before the procedure,
  • Absence of a disease that may cause chronic pain,
  • No regular invasive intervention (no chronic disease requiring blood control such as cancer, diabetes).

IPD Sharing Time Frame

always

IPD Sharing Access Criteria

Considering that repeated attempts may increase pain and anxiety in children, blood sampling cannot be performed in the first attempt,

  • Children in the control group wanting or involuntarily holding their parents' hand or anything during the procedure,
  • Failure to enter the vein within 20 seconds of grasping the ball,
  • Failure to take blood from the cephalic vein,
  • The children in the experimental group let go of the ball in their hands during the procedure.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nurse's Role

Clinical Trials on The group holding the serrated ball in the hand on the extremity from which venous blood will be taken

Subscribe